Altria Lights Up With Strong Growth In Its Smoke-Free Portfolio
Portfolio Pulse from
Altria is experiencing growth in its smoke-free product portfolio, with NJOY and on! brands gaining volume. NJOY's device shipments tripled in Q3 2024, aided by FDA approval of menthol e-cigarettes, increasing its market share to 6.2%. However, challenges include illicit e-vapor products and a patent dispute with Juul.
November 06, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Altria's smoke-free product portfolio is growing, with NJOY's shipments tripling in Q3 2024 and gaining a 6.2% market share. FDA approval of menthol e-cigarettes supports this growth, but risks include illicit e-vapor products and a patent dispute with Juul.
Altria's focus on smoke-free products is paying off with significant growth in NJOY's market share, supported by FDA approval. However, the presence of illicit products and legal issues with Juul could impact future growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100